Ball Titus B. 4

4 · BeOne Medicines Ltd. · Filed Jun 10, 2026

AI-generated summary of this filing

Updated Jun 10, 2026

BeOne Medicines (ONC) Principal Accounting Officer Titus B. Ball Sells Shares

What Happened

Titus B. Ball, Principal Accounting Officer of BeOne Medicines Ltd. (ONC), sold a total of 136 American Depositary Shares (ADS) on June 8, 2026. The sales consisted of 100 ADS at a weighted average price of $271.06 (proceeds $27,106) and 36 ADS at a weighted average price of $272.08 (proceeds $9,795), for aggregate proceeds of $36,901. These sales were effected to satisfy mandatory tax withholding in connection with the vesting of restricted share units (RSUs).

Key Details

Transaction date: June 8, 2026; Form 4 filed June 10, 2026 (timely filing).
Shares sold: 100 ADS @ $271.06 (weighted avg), 36 ADS @ $272.08 (weighted avg); total 136 ADS; total proceeds $36,901.
Price ranges: the 100-ADS tranche sold across prices from $271.00 to $271.48; the 36-ADS tranche sold across $272.00 to $272.24. Weighted averages reported; breakdowns available from the filer on request (per footnotes).
Reason for sale: Mandatory tax withholding related to RSU vesting (footnote). Vesting schedule noted: 1/4 of the securities vest each anniversary of June 5, 2024, subject to continued service.
ADS conversion: Each ADS represents 13 ordinary shares — 136 ADS = 1,768 ordinary shares.
Shares owned after transaction: Not specified in the provided filing.

Context

These sales were made as tax-withholding exits tied to RSU vesting (routine, non-discretionary) rather than open-market investment-driven sales; such withholding transactions are common and do not necessarily signal a change in the insider’s view of the company.

Form 4

Period: 2026-06-08

Principal Accounting Officer

Transactions

Sale
American Depositary Shares
[F1][F2][F3]
2026-06-08$271.06/sh−100$27,106→ 36 total
Sale
American Depositary Shares
[F1][F2][F4]
2026-06-08$272.08/sh−36$9,795→ 0 total

Holdings

Footnotes (4)

[F1]Each American Depositary Share represents 13 Ordinary Shares.
[F2]The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $271.00 to $271.48, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.00 to $272.24, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Signature

/s/ Qing Nian, as Attorney-in-Fact|2026-06-10

1 file